Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Bereznicki

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Research in Social & Administrative Pharmacy : RSAP|October 1, 2021
Preventing Adverse Drug Reactions After Hospital Discharge (PADR-AD): Protocol for a randomised-controlled trial in older peopleJustin Cousins, Nibu Parameswaran Nair, Colin Curtain, et al.
Plos One|January 5, 2023
Healthcare expenditure and its socio-demographic and clinical predictors in Australians with poorly controlled asthmaStella T Lartey, Thomas Lung, Sarah Serhal, et al.
Journal of the American Pharmacists Association : Japha|March 14, 2022
Pharmacist-delivered asthma management services-what do patients think?Sarah Serhal, Bandana Saini, Sinthia Bosnic-Anticevich, et al.
Drugs & Aging|November 24, 2022
Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trialGereltuya Dorj, Nibu Parameswaran Nair, Luke Bereznicki, et al.
American Journal of Pharmaceutical Education|August 17, 2021
A Multi-Mode Education Program to Enhance Asthma Care by PharmacistsSarah Serhal, Bandana Saini, Sinthia Bosnic-Anticevich, et al.
Drug Safety|April 19, 2023
Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR TrialLisa M Kalisch Ellett, Gerel Dorj, Andre Q Andrade, et al.
Frontiers in Pharmacology|January 13, 2022
A Targeted Approach to Improve Asthma Control Using Community PharmacistsSarah Serhal, Bandana Saini, Sinthia Bosnic-Anticevich, et al.
BMJ Open|April 25, 2020
Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcomeRenly Lim, Luke Bereznicki, Megan Corlis, et al.
Age and Ageing|April 23, 2022
Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial)Elizabeth E Roughead, Nicole L Pratt, Gaynor Parfitt, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Research in Social & Administrative Pharmacy : RSAP|October 1, 2021
Preventing Adverse Drug Reactions After Hospital Discharge (PADR-AD): Protocol for a randomised-controlled trial in older peopleJustin Cousins, Nibu Parameswaran Nair, Colin Curtain, et al.
Plos One|January 5, 2023
Healthcare expenditure and its socio-demographic and clinical predictors in Australians with poorly controlled asthmaStella T Lartey, Thomas Lung, Sarah Serhal, et al.
Journal of the American Pharmacists Association : Japha|March 14, 2022
Pharmacist-delivered asthma management services-what do patients think?Sarah Serhal, Bandana Saini, Sinthia Bosnic-Anticevich, et al.
Drugs & Aging|November 24, 2022
Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trialGereltuya Dorj, Nibu Parameswaran Nair, Luke Bereznicki, et al.
American Journal of Pharmaceutical Education|August 17, 2021
A Multi-Mode Education Program to Enhance Asthma Care by PharmacistsSarah Serhal, Bandana Saini, Sinthia Bosnic-Anticevich, et al.
Drug Safety|April 19, 2023
Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR TrialLisa M Kalisch Ellett, Gerel Dorj, Andre Q Andrade, et al.
Frontiers in Pharmacology|January 13, 2022
A Targeted Approach to Improve Asthma Control Using Community PharmacistsSarah Serhal, Bandana Saini, Sinthia Bosnic-Anticevich, et al.
BMJ Open|April 25, 2020
Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcomeRenly Lim, Luke Bereznicki, Megan Corlis, et al.
Age and Ageing|April 23, 2022
Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial)Elizabeth E Roughead, Nicole L Pratt, Gaynor Parfitt, et al.
Pageof 4